Sidvim LifeSciences Private Limited

  Contents DMFs filed in the month of August 2023 General information New cost-cap system for UK patent disputes to start in early 2024 Delhi HC Grants ₹11 Lakh Damages To Woodland Intellectual Property Cloudbreak vs Allgenesis DMFs filed in the month of August 2023 In August 2023,  total 72, Type-II DMFs were filed, out of which about 23 DMFs were filed by Indian companies, Aurobindo and MSN were at the top of list by filing 3 DMFs each. Chinese companies had overtaken Indian DMF filings in August. Chinese companies filed 25 DMFs. In last few quarters there’s increase in DMF filings by Chinese companies.  Some of our product specific observations are as below. HOLDER SUBJECT COMMENTS MSN LIFE SCIENCES PRIVATE LIMITED TRAZODONE HYDROCHLORIDE USP This is very old API and 12 other DMF holders. Several ANDA filers too. Trazodone is used to treat depression. It is medium volume API, priced at around USD 100/KG INTAS PHARMACEUTICALS LTD BENDAMUSTINE HYDROCHLORIDE There are 20 ot

  Contents DMFs filed in the month of July 2023 General information EPO revokes Moderna patent in vaccine dispute with BioNTech Following Recent Policy Statement, FTC ‘Disputes’ 100+ Patent Listings in FDA Orange Book Intellectual Property Rivaroxaban- Netherlands DMFs filed in the month of July 2023 We follow DMFs filed by Indian companies. FDA publishes this list every quarter. So, during first week of last month FDA must have published the list of DMF filed in Q3 2023, but we missed to analyse it the last month.  In July 2023,  total 56, Type-II DMFs were filed, out of which about 23 DMFs were filed by Indian companies, Cipla and Biphore are at the top of list by filing 3 each in July 2023. Chinese companies are not far behind. Chinese companies filed 18 DMFs in July 2023. In last few quarters there’s increase in DMF filings by Chinese companies.  Some of our product specific observations are as below. HOLDER SUBJECT Comments MAHI DRUGS  ALBENDAZOLE USP Very old product,